Abstract: The invention relates to a device for providing pressurized fluid. The device includes a first functional assembly including a pressurized fluid bottle having an opening having attached therein a first tap including an inner fluid circuit including an insulating valve. The device includes a second functional assembly forming a physical entity separate from the first assembly. The second assembly includes a second tap having an inner fluid circuit. The first tap and the second tap include respective coupling members forming a removable rapid connection system. The device includes in the first assembly at least one electronic data storage communication unit that is removably, wirelessly queryable via electromagnetic waves and in that the second assembly includes at least one electronic communication unit for removably, wirelessly reading, via electromagnetic waves, data from the electronic member of the first assembly.

Abstract: The present invention concerns a compound, a salt of this compound, a derivative of this compound or a salt of this derivative, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins, and its cosmetic applications for stimulating or repairing the barrier function of the epidermis and its pharmaceutical applications for treating lesions caused by pathologies, such as Crohn's disease.

Abstract: The invention relates to a pressure gauge comprising a dial comprising a marking and a pressure indicator configured to rotate with respect to the dial, the pressure indicator changing orientation and/or position relative to the markings as it rotates. The marking comprises a two-dimensional code that encodes at least one given information item. The pressure gauge comprises a graphic reference acting as a reference position so that the pressure indicator can be positioned in space. The invention also relates to a valve unit for distributing fluid, particularly gas, comprising such a pressure gauge and an assembly for distributing fluid, particularly gas, comprising a gas container, such as a gas cylinder, to which such a fluid distribution valve unit equipped with such a pressure gauge is fixed. Another aspect of the invention also relates to a method for measuring the pressure displayed by a pressure gauge.

Abstract: An electric field sensor includes sense and reference cells. The sense cell produces a resistance that varies relative to an intensity of an electric field, and the reference cell produces a resistance that is invariable relative to the intensity of the electric field. An output signal indicative of the intensity of the electric field is determined using the difference between the resistances. A system includes an electric field source that outputs a digital test program as an electric field signal. The system further includes the electric field sensor formed with IC dies on a wafer. The electric field sensor receives the electric field signal. The received electric field signal is converted to the test program, and the test program is stored in memory on the wafer. The electric field source does not physically contact the dies, but can flood an entire surface of the wafer with the electric field signal.

Abstract: A differential-logic logic circuit chained with another differential-logic circuit comprises a first logic cell composed of back-gate transistors, the first cell having a first input for receiving a first input signal and having an output for delivering a first output signal, and a second logic cell complementary to the first cell, composed of back-gate transistors, the second cell having as many inputs as the first cell, each input able to receive an input signal complementary to the respective input signal of the first cell, the second cell having an output for delivering a second output signal complementary to the first output signal of the first cell. The first output signal of the first cell is applied to the back gate of each transistor of the second cell, and the second output signal of the second cell is applied to the back gate of each transistor of the first cell.

Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.

Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.

Abstract: A fission chamber count rate measurement device and to the associated fission chamber calibration device; the count rate measurement device comprises: (1) a measurement cell, which contains the fission chamber (CH); (2) a neutron generator, which emits neutrons in the form of periodic pulses towards the fission chamber; (3) a neutron counter (K), which detects and counts the neutrons emitted by the neutron generator; and (4) a computing circuit, which delivers, over a predetermined time interval, a fission chamber count rate normalized with reference to the number of neutrons counted by the neutron counter (K).

Abstract: A movable device for measuring physical quantities of nuclear materials contained in a shielded cell, which device can be brought up against the shielded cell and can be retracted therefrom, the device configured to carry out the measurement in the position in which it is against the shielded cell. The device includes a carriage, a support member placed on the carriage, and a shielded container placed on the support member. The shielded container includes a transfer container configured to store the nuclear material to be measured, and an opening configured to be aligned with an opening in one wall of the shielded cell. The support member is made of graphite and includes a housing accommodating a neutron emission module, a casing covering the shielded container, the casing being made of graphite, and a neutron measurement mechanism fastened to the casing.

Abstract: A technique includes receiving seismic data acquired by seismic sensors; and processing the seismic data on a machine to deghost the data. The processing includes deghosting the seismic data using a first deghosting technique that relies on a ghost model; deghosting the seismic data using a second deghosting technique that is independent from any modeling of the ghost; and selectively combining the results of the deghosting using the first and second deghosting techniques.

Abstract: The invention relates to a device for measuring patient compliance with oxygen therapy, including a casing (4) comprising means for detection of the oxygen therapy in order to evaluate data relating to the treatment; and means for measuring a state of physical activity of the patient. Preferably, the means for measuring a state of physical activity of the patient comprise at least one sensor which senses movement of the patient's body and outputs data relating to the spatial displacement of the patient's body, for example a three-dimensional accelerometer (28); and processing means (40, 42) for processing the body displacement data in order to supply a state of physical activity of the patient chosen from a sleeping state, a resting state and an active state.

Abstract: Describe is a method of administering to a subject silymarin, or of the main constituents thereof alone or as a mixture, chosen from silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3, 5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isosilybin, silydianin, silychristin, silandrin, silymonin and taxifolin, isolated enantiomers thereof and also salts thereof.

Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.

Abstract: A mobile floor device for a swimming pool including a stationary floor, standing lateral walls, a mobile floor and a mechanism for pulling said mobile floor. The pulling mechanism includes cables and drivers driving the cables in one direction or in a reverse direction. Each cable having a first end connected to the mobile floor and a second end connected to the swimming pool. For each cable, at least one driver drives a maximum of one cable. The drivers are attached either to the swimming pool or to the mobile floor with the lengths of the cables between the drivers and the mobile floor and the swimming pool, respectively, being substantially equal to one another.

Abstract: A technique includes receiving seismic data acquired by seismic sensors; and processing the seismic data on a machine to deghost the data. The processing includes deghosting the seismic data using a first deghosting technique that relies on a ghost model; deghosting the seismic data using a second deghosting technique that is independent from any modeling of the ghost; and selectively combining the results of the deghosting using the first and second deghosting techniques.

Abstract: A movable device for measuring physical quantities of nuclear materials contained in a shielded cell, which device can be brought up against the shielded cell and can be retracted therefrom, the device configured to carry out the measurement in the position in which it is against the shielded cell. The device includes a carriage, a support member placed on the carriage, and a shielded container placed on the support member. The shielded container includes a transfer container configured to store the nuclear material to be measured, and an opening configured to be aligned with an opening in one wall of the shielded cell. The support member is made of graphite and includes a housing accommodating a neutron emission module, a casing covering the shielded container, the casing being made of graphite, and a neutron measurement mechanism fastened to the casing.

Abstract: The invention relates to the use of 2,2?-cyclolignanes in the cosmetic or pharmaceutical field for inducing, restoring or stimulating the pigmentation of the skin, hair or hairs.

Abstract: A fission chamber count rate measurement device and to the associated fission chamber calibration device; the count rate measurement device comprises: (1) a measurement cell, which contains the fission chamber (CH); (2) a neutron generator, which emits neutrons in the form of periodic pulses towards the fission chamber; (3) a neutron counter (K), which detects and counts the neutrons emitted by the neutron generator; and (4) a computing circuit, which delivers, over a predetermined time interval, a fission chamber count rate normalized with reference to the number of neutrons counted by the neutron counter (K).

Abstract: The invention relates to a compound that inhibits a metallo-ectopeptidase, selected in the group consisting of x-aa2-aa1-z, x-aa3-aa2-aa1-z, x-aa4-aa3-aa2-aa1-z and x-aa5-aa4-aa3-aa2-aa1-z, wherein: aa1 and aa4, independently from each other, represent an arginine amino acid, an histidine amino acid, an asparagine amino acid or a lysine amino acid, aa2 represents a serine amino acid, a glycine amino acid, a threonine amino acid or an alanine amino acid, aa3 represents a phenylalanine amino acid, a leucine amino acid, an isoleucine amino acid, a tyrosine amino acid or a tryptophan amino acid, aa5 represents a glutamine amino acid, a glutamic acid amino acid, an asparagines amino-acid or a lysine amino acid, x and z, independently from each other, represent: —H; —OH1 SH; —a halogen atom, —an amino group, —an alkyl, haloalkyl or heteroalkyl group containing from 1 to 30 carbon atoms, linear or branched, —an alkenyl or alkynyl group containing from 2 to 30 carbon atoms, linear or branched, —a cycloalkyl, cycloake

Abstract: The invention relates to novel derivatives capable of increasing the synthesis and/or the release of neurotrophic factors, and therefore able to be used as a human or veterinary medicinal product. The invention also relates to methods for preparing the derivatives and also to the intermediates required for their synthesis.